MARLA LEHMANN: Open Payments
NPI 1487824710 · CARROLLTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 54 payments from 23 companies in 2025. Trend: 2023 $1,379 · 2024 $1,000 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $167 |
| AstraZeneca Pharmaceuticals LP | 2 | $151 |
| GlaxoSmithKline, LLC. | 7 | $129 |
| Abbott Laboratories | 4 | $112 |
| Gilead Sciences, Inc. | 3 | $76 |
| ABBVIE INC. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $51 |
| Astellas Pharma US Inc | 3 | $51 |
Products named: BREZTRI, Wegovy, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Auvelity, CONFIRM RX, Veozah, UBRELVY.
Industry payments across TX — which companies pay providers there.
